Indraprastha Medical Corporation Ltd
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
- Market Cap ₹ 3,809 Cr.
- Current Price ₹ 416
- High / Low ₹ 572 / 211
- Stock P/E 23.6
- Book Value ₹ 65.1
- Dividend Yield 1.07 %
- ROCE 39.0 %
- ROE 30.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 29.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.3%
- Company has been maintaining a healthy dividend payout of 30.3%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
678 | 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | |
587 | 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,050 | 1,112 | |
Operating Profit | 91 | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 244 |
OPM % | 13% | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% |
1 | 1 | 1 | -0 | -1 | -1 | -0 | -0 | -3 | 9 | 16 | 23 | |
Interest | 10 | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 |
Depreciation | 28 | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 |
Profit before tax | 54 | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 |
Tax % | 35% | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | 25% | 26% |
35 | 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | |
EPS in Rs | 3.87 | 3.54 | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 |
Dividend Payout % | 47% | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% | 33% | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 10% |
3 Years: | 15% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | 29% |
3 Years: | 37% |
TTM: | 29% |
Stock Price CAGR | |
---|---|
10 Years: | 22% |
5 Years: | 62% |
3 Years: | 91% |
1 Year: | 71% |
Return on Equity | |
---|---|
10 Years: | 19% |
5 Years: | 23% |
3 Years: | 28% |
Last Year: | 30% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
Reserves | 95 | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 |
63 | 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | |
199 | 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | |
Total Liabilities | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 |
293 | 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | |
CWIP | 2 | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
154 | 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | |
Total Assets | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
58 | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 | |
-22 | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 | |
-36 | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 | |
Net Cash Flow | 0 | -0 | -0 | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 |
Inventory Days | 11 | |||||||||||
Days Payable | 194 | |||||||||||
Cash Conversion Cycle | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | -163 |
Working Capital Days | -19 | -23 | 0 | 14 | 12 | -5 | -8 | 0 | -1 | -11 | -24 | -18 |
ROCE % | 26% | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Submission of Annual Secretarial Compliance Report for FY ended 31 March 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Copies of the public notice of financial results, published on 17th May, 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting
16 May - Approved FY25 audited results with unmodified opinion; recommended 45% dividend (Rs.4.50/share).
-
Board Meeting Intimation for Board Meeting On 16Th May, 2025
5 May - Board meeting on May 16 to approve FY25 results and consider dividend.
-
Announcement under Regulation 30 (LODR)-Credit Rating
28 Apr - ICRA reaffirms [ICRA]AA and [ICRA]A1+ ratings; assigns [ICRA]AA for Rs.100 Cr term loan.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]